Personalized chordoma organoids for drug discovery studies
A Al Shihabi, A Davarifar, HTL Nguyen, N Tavanaie… - Science …, 2022 - science.org
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
Personalized chordoma organoids for drug discovery studies
AA Shihabi, A Davarifar, HT Lam Nguyen, N Tavanaie… - bioRxiv, 2021 - biorxiv.org
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Primary treatment of chordoma is surgery, however complete resection is not …
skull base. Primary treatment of chordoma is surgery, however complete resection is not …
[PDF][PDF] Personalized chordoma organoids for drug discovery studies
A Al Shihabi, A Davarifar, HTL Nguyen, N Tavanaie… - researchgate.net
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Primary treatment of chordoma is surgery, however complete resection is not …
skull base. Primary treatment of chordoma is surgery, however complete resection is not …
Personalized chordoma organoids for drug discovery studies
A Al Shihabi, A Davarifar, HTL Nguyen… - Science …, 2022 - scholarship.miami.edu
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
[HTML][HTML] Personalized chordoma organoids for drug discovery studies
A Al Shihabi, A Davarifar, HTL Nguyen… - Science …, 2022 - ncbi.nlm.nih.gov
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
[PDF][PDF] Personalized chordoma organoids for drug discovery studies
A Al Shihabi, A Davarifar, HTL Nguyen, N Tavanaie… - scholar.archive.org
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Primary treatment of chordoma is surgery, however complete resection is not …
skull base. Primary treatment of chordoma is surgery, however complete resection is not …
Personalized chordoma organoids for drug discovery studies
AA Shihabi, A Davarifar, HT Lam Nguyen, N Tavanaie… - 2021 - escholarship.org
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Primary treatment of chordoma is surgery, however complete resection is not …
skull base. Primary treatment of chordoma is surgery, however complete resection is not …
Personalized chordoma organoids for drug discovery studies
A Al Shihabi, A Davarifar, HTL Nguyen… - Science …, 2022 - pubmed.ncbi.nlm.nih.gov
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
Personalized chordoma organoids for drug discovery studies
A Al Shihabi, A Davarifar, HTL Nguyen… - Science …, 2022 - ui.adsabs.harvard.edu
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
Personalized chordoma organoids for drug discovery studies.
A Al Shihabi, A Davarifar, HTL Nguyen… - Science …, 2022 - europepmc.org
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …